Legal & General Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2K | Buy |
6,765
+454
| +7% | +$1.69K | ﹤0.01% | 2912 |
|
|
2025
Q1 | $17.4K | Hold |
6,311
| – | – | ﹤0.01% | 2989 |
|
|
2024
Q4 | $35K | Buy |
6,311
+1,234
| +24% | +$6.84K | ﹤0.01% | 2848 |
|
|
2024
Q3 | $42.3K | Buy |
5,077
+23
| +0.5% | +$192 | ﹤0.01% | 2815 |
|
|
2024
Q2 | $34.4K | Sell |
5,054
-22,479
| -82% | -$153K | ﹤0.01% | 2855 |
|
|
2024
Q1 | $181K | Sell |
27,533
-89
| -0.3% | -$584 | ﹤0.01% | 2691 |
|
|
2023
Q4 | $179K | Hold |
27,622
| – | – | ﹤0.01% | 2716 |
|
|
2023
Q3 | $139K | Buy |
27,622
+2,021
| +8% | +$10.2K | ﹤0.01% | 2788 |
|
|
2023
Q2 | $224K | Buy |
+25,601
| New | +$224K | ﹤0.01% | 2711 |
|
|
2022
Q2 | – | Sell |
-1,454
| Closed | -$4K | – | 3651 |
|
|
2022
Q1 | $4K | Buy |
1,454
+175
| +14% | +$481 | ﹤0.01% | 3522 |
|
|
2021
Q4 | $9K | Hold |
1,279
| – | – | ﹤0.01% | 3478 |
|
|
2021
Q3 | $13K | Buy |
1,279
+400
| +46% | +$4.07K | ﹤0.01% | 3404 |
|
|
2021
Q2 | $11K | Hold |
879
| – | – | ﹤0.01% | 3413 |
|
|
2021
Q1 | $19K | Buy |
+879
| New | +$19K | ﹤0.01% | 3154 |
|